Content (click an entry for fast navigation to the subject)Clinical transfusion in the medical settingAnaemiaFeatures of patients seen in a medical or surgical contextNutritional anaemiasTreatment of iron deficiencyOral ironParenteral iron preparationsPrecautionsAnaemia of chronic disease (ACD)Anaemia in patients with cancerEpoetin in anaemic cancer patientsRed cell transfusion in anaemiaWhat haemoglobin concentration should be maintained?Complications of long-term red cell transfusionHaemoglobinopathiesβ-thalassaemia majorSickle-cell diseaseHaemoglobinopathy traitAnaemia in chronic renal failureAnaemiaImmunological sensitisationCongenital haemostatic disordersPatients with haemophilia A, haemophilia B and von Willebrand's diseaseInitial care of a patient with haemophilia who has a bleedVon Willebrand's diseaseBone marrow failure due to disease, cytotoxic therapy or irradiationABO and RhD compatibility of platelet transfusionsPlatelet refractorinessManagement of refractorinessRed cell transfusionPrevention of transfusion-associated graft-versus-host diseasePrevention of cytomegalovirus transmissionImmunological disorders - use of immunoglobulinPrimary antibody deficiency (primary hypogammglobulinaemia)Secondary antibody deficiencyDosage and administration of IVIgG and SCIgG in antibody deficiencyImmunomodulatory therapy with high-dose intravenous immunoglobulinAdverse events associated with high-dose IVIgGTherapeutic plasma exchangeClinical indications for therapeutic plasma exchangeThrombotic thrombocytopenic purpuraRisks of TpEApheresis to remove other abnormal blood constituentsImmunoadsorption
Content (click an entry for fast navigation to the subject)
Clinical transfusion in the medical setting
Anaemia
Features of patients seen in a medical or surgical context
Nutritional anaemias
Treatment of iron deficiency
Oral iron
Parenteral iron preparations
Precautions
Anaemia of chronic disease (ACD)
Anaemia in patients with cancer
Epoetin in anaemic cancer patients
Red cell transfusion in anaemia
What haemoglobin concentration should be maintained?
Complications of long-term red cell transfusion
Haemoglobinopathies
β-thalassaemia major
Sickle-cell disease
Haemoglobinopathy trait
Anaemia in chronic renal failure
Immunological sensitisation
Congenital haemostatic disorders
Patients with haemophilia A, haemophilia B and von Willebrand's disease
Initial care of a patient with haemophilia who has a bleed
Von Willebrand's disease
Bone marrow failure due to disease, cytotoxic therapy or irradiation
ABO and RhD compatibility of platelet transfusions
Platelet refractoriness
Management of refractoriness
Red cell transfusion
Prevention of transfusion-associated graft-versus-host disease
Prevention of cytomegalovirus transmission
Immunological disorders - use of immunoglobulin
Primary antibody deficiency (primary hypogammglobulinaemia)
Secondary antibody deficiency
Dosage and administration of IVIgG and SCIgG in antibody deficiency
Immunomodulatory therapy with high-dose intravenous immunoglobulin
Adverse events associated with high-dose IVIgG
Therapeutic plasma exchange
Clinical indications for therapeutic plasma exchange
Thrombotic thrombocytopenic purpura
Risks of TpE
Apheresis to remove other abnormal blood constituents
Immunoadsorption